- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩6.5t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩82,900.00
7D
-4.7%
1Y
-9.2%
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩35,150.00
7D
-5.4%
1Y
18.2%
JW Shinyak
Market Cap: ₩134.7b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,410.00
7D
3.2%
1Y
56.1%
DongKoo Bio & Pharma
Market Cap: ₩95.6b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩3,535.00
7D
-9.8%
1Y
-31.5%